ReviewInternational journal of molecular sciences2026
Advances in Somatostatin Receptor-Targeting Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Biological Rationale, Combination Strategies, and Clinical Perspectives.
Hana Bakr et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.